← Back to list
Patient Capital ManagementArticle27 Jan 2026Source: patientcapitalmanagement.com

4Q25 Quarterly Webinar

Patient Capital Management is a Baltimore asset manager founded in 2020 by Samantha McLemore, CFA — Bill Miller's long-time co-manager (working together since 2002, running the flagship Opportunity Equity strategy since 2014). Continuing the Miller-school contrarian tradition, it practices "time arbitrage": exploiting behavioral mispricing to concentrate in controversial growth names (tech, healthcare, Bitcoin-related) at deep discounts to intrinsic value. Its site preserves Bill Miller's complete 1995-2022 market letters, alongside ongoing quarterly letters and webinars.

Samantha McLemore · 2020 · 美国巴尔的摩Contrarian growth-value / time arbitrage

In plain words

Patient Capital's webinar explains how they consistently beat the market. Their secret: sticking to long-term thinking and exploiting market emotions (like excessive pessimism) to buy good companies cheap. They're especially bullish on healthcare now, because it's at 50-year lows in valuation despite stable earnings. They also think the bull market may continue, similar to the late 1990s. For ordinary investors, the key is to stay patient, ignore short-term noise, and choose fund managers who invest their own money alongside you.

AI SummaryAI-generated · may contain errors · verify against the original

The Patient Opportunity Equity Strategy report from Patient Capital discusses its investment philosophy and process since its inception in 2020 and full independence in 2023. The core argument is a commitment to value investing, comparing enterprise value with market expectations through deep fundam

~37 min full read · 27 sections
Deep Analysis

Theme and Background

This section is the opening part of the Patient Capital webinar held on January 22, 2026. It primarily introduces the company's history, investment philosophy, team background, and current market views. The author aims to clarify its unique value investing framework and long-term perspective to investors, while sharing judgments on the current market environment.

Core Views

  • Investment Philosophy Originates from Over 40 Years of History: The author emphasizes that the investment philosophy and process originated from Bill Miller and Ernie Kiehne during their time at Legg Mason (over 40 years ago) and have been continuously refined, which is the "secret weapon."
  • Markets Are Correct Most of the Time, Excess Returns Come from Behavioral Biases: The author believes the market is extremely efficient, but emotional and short-sighted behavioral biases at the individual and institutional levels create mispricing opportunities, which are the most enduring source of excess returns.
  • Currently in the Late Stage of a Long-Term Bull Market, But It May Continue: The author judges that the long-term bull market that began in March 2009 is still ongoing and is in its late stage. However, the late stage may offer the best returns, similar to the late 1990s.
  • Value Investing Overall Lags, But Patient Capital Outperforms: Although the value style has lagged for a long time, Patient Capital has performed well during this period due to its flexibility and in-depth research.

Key Arguments and Data

  • Long-Term Bull Market Performance: Since March 2009, the S&P 500 has delivered an annualized return of nearly 17%, far above the long-term average of slightly below 10%.
  • Value Stock Performance: The S&P 500 Value Index (including Microsoft, Amazon, etc.) has an annualized return of 14.8% over the same period.
  • Comparison with the Late 1990s:
  • In the late 1990s (1995-1999), the S&P 500 posted returns exceeding 20% for five consecutive years, with a cumulative gain of 250% over five years and an annualized return of 28.5%.
  • Currently (as of 2025), the S&P 500's three-year annualized return is 23%, and it has not yet seen three consecutive years of returns exceeding 20%.
  • Team Incentives: The author invests most of his liquid assets in the fund; under the analysts' long-term incentive plan, a significant portion of bonuses vests over five years only if the fund outperforms the market.

Companies/Assets Involved

  • QXO: Patient Capital participated in its PIPE (Private Investment in Public Equity) transaction, but no specific data was provided.
  • Precigen: Patient Capital led its transaction, and this investment contributed significantly to 2025 returns.
  • S&P 500 Index: Used as a market benchmark to measure overall market performance.
  • S&P 500 Value Index: Used as a value style benchmark; the author believes it includes companies like Microsoft and Amazon, making it a fair comparison.

Investment Implications

  • Long-Term Perspective is Core: Investors should focus on the gap between a company's fundamental value and market expectations, rather than short-term market fluctuations or news.
  • Behavioral Biases are a Source of Excess Returns: Look for mispriced assets during extreme market sentiment (e.g., extreme pessimism or optimism).
  • Current Market Environment Resembles the Late 1990s: Although in the late stage of a long-term bull market, strong returns may still be possible, and investors should not exit prematurely.
  • Value Investing Still Has Opportunities: Although the value style overall lags, excess returns can still be generated through in-depth research and flexible strategies (e.g., using derivatives, PIPE).
  • Pay Attention to Fund Manager Incentive Structures: Choose funds with strong alignment of interests with investors (e.g., fund managers with significant personal investments, incentive plans tied to long-term performance).

Sequel Analysis: Deep Game of Market Sentiment, Earnings Growth, and Valuation Dispersion

1. Earnings Growth: Shift from "Recession Pricing" to "Accelerating Growth"

Speaker 2 emphasizes that in 2022, the market widely expected a recession, leading to many cyclical value stocks being "fully priced for recession." This pessimistic expectation created a low base effect for the rebound in 2023-2024. Key data points:

  • 2024 Earnings Growth: Nearly 10%, higher than expectations at the beginning of the year.
  • 2025 Expectations: Approximately 12%, with "bottom-up" forecasts showing nearly 14% for 2026, indicating an accelerating trend.
  • 2026 Target: Estimated growth of 13.6%; even if actual results are slightly lower, double-digit growth would still support a strong market.

Comparative Data: Correlation between earnings growth expectations and market performance

Year Earnings Growth Expectation Actual Market Return (S&P 500) Valuation Change (PE)
2024 ~10% +25% 22.1x (start) → Slightly above 22x (end)
2025 ~12% To be verified 22.1x (start) → Roughly flat
2026 ~14% To be verified To be verified

Key Insight: The 2024 market return (+25%) far exceeded earnings growth (~10%), but valuation expansion was limited (PE only slightly increased from 22.1x), indicating that returns were primarily driven by earnings beats and sentiment repair, not a bubble. This differs from the 2021 "earnings growth + valuation expansion" double-hit model.

2. Market Sentiment: Gradual Shift from "Pessimism" to "Optimism," But Not Yet "Euphoria"

Speaker 2 cites Sir John Templeton's cycle theory: bull markets are born in pessimism, grow in skepticism, mature in optimism, and die in euphoria. Current state:

  • Pessimism Phase: 2022, market priced in recession.
  • Skepticism Phase: 2023-early 2024, Wall Street strategists remained bearish (expected decline in 2023, actual surge; expected flat in 2024, actual +25%).
  • Optimism Phase: 2025, strategists expect "low double-digit returns," but the Barron's Roundtable turned bullish for the first time (had not been bullish from 2022-2025).
  • Euphoria Signs: Some areas (quantum stocks, nuclear stocks) trade at "infinite revenue multiples" (no revenue or hundreds of times revenue), but overall market still has skepticism (e.g., AI bubble concerns).

Sentiment Indicators:

  • Citi Panic/Euphoria Index: Consistently shows "greed," but not extreme.
  • Fund Flows: Record inflows, but valuation concerns coexist.
  • Key Contradiction: Tech stocks (e.g., Meta, Nvidia) trade at below-market multiples despite strong growth (Nvidia growing 60%+). Speaker 2 believes the "scar effect" from the tech bubble and financial crisis suppresses euphoria, helping sustain the bull market.
3. Valuation: Historically High but Low Short-Term Correlation, Dispersion Creates Opportunities
  • Current Valuation: Market PE around 22.1x, historically high, but R-squared analysis shows:
  • 1-Year: Correlation between valuation and return is nearly zero (R²≈0), not a key short-term driver.
  • 5-Year: Correlation rises to 0.25, explaining 25% of returns.
  • 10-Year: Correlation reaches 0.75; historically high levels (e.g., above 20x) usually signal poor long-term returns, but sample size is small (mostly from the tech bubble).
  • Fair Valuation: The current "fair multiple" is significantly higher than history due to higher return on equity (ROE), free cash flow, and profit margins. The market is "roughly fair," slightly above fair value.
  • Dispersion: The median PE is 18.8x (higher than the long-term average of 16.3x, but only 15% higher), but the high and low ends are extremely divergent:
  • High Valuation End: Close to 2021 and 1999-2000 highs.
  • Low Valuation End: Value stocks are not valued above historical levels; value strategies have performed poorly (many managers forced to adjust or shut down).

Comparative Data: Valuation Dispersion vs. Historical Extremes

Indicator Current Value Historical Average/Extreme Remarks
Median PE 18.8x 16.3x (long-term) Only 15% higher, not extreme
High Valuation End (Top 10%) Close to 2021 highs 1999-2000 peak Tech-driven, but not a full market bubble
Low Valuation End (Bottom 10%) Not exceeding historical average Long-term stable Value stocks overlooked, creating opportunities

Investment Implications: Dispersion provides opportunities for stock pickers (especially value-oriented). Speaker 2 emphasizes "providing liquidity" and "patiently waiting for value convergence," but warns against fundamental misjudgment.

4. Sector Allocation: Extreme Undervaluation Opportunity in Healthcare
  • Portfolio Weight: Healthcare accounts for 27.6% of the portfolio (S&P weight is only 9.6%), the largest overweight.
  • Valuation Context: Healthcare's relative valuation has fallen to a 50-year low, extremely undervalued.
  • Performance: Rebounded in Q4 2024, but the magnitude was limited (chart shows "barely visible").
  • Logic: Non-cyclical, high-return, provides portfolio resilience, especially suitable for expected market corrections (Speaker 2 expects a correction in 2025).

Comparative Data: Healthcare vs. Overall Market

Indicator Healthcare (Portfolio) S&P 500 (Benchmark) Difference
Weight 27.6% 9.6% +18% overweight
Relative Valuation (Historical Percentile) 50-year low Historical high Extreme undervaluation
Cyclicality Non-cyclical Mixed Defensive advantage
5. Portfolio Performance and Risk Warnings
  • Performance: Since Speaker 2 took independent management at the end of 2022, the portfolio has an annualized return of 23% (in line with the S&P 500), benefiting from a strong market.
  • 2025 Contributors: Precigen (privatization transaction, completed in December 2024) was the largest contributor; CEO Helen Sabzevari performed well during the pandemic, but the company had a weak balance sheet.
  • Risk: Speaker 2 acknowledges "expects a correction this year," but believes non-cyclical holdings like healthcare can provide a buffer.

Summary: Sequel Core Arguments

1. Earnings Growth is the Core Driver: Accelerating growth (10%→12%→14%) supports the market; even with high valuations, short-term correlation is low.

2. Sentiment Not Yet Euphoric: Skepticism and optimism coexist; tech stock valuations are restrained (due to historical scars); some areas (quantum, nuclear) have bubbles, but overall healthy.

3. Valuation Dispersion Creates Opportunities: Value stocks are overlooked; extremely undervalued areas like healthcare provide a margin of safety.

4. Portfolio Strategy: Overweight non-cyclical, high-return sectors (healthcare); patiently wait for value convergence; be wary of fundamental misjudgment risks.

Key Risks: If earnings growth disappoints (e.g., 2026 14% target missed), or sentiment turns to euphoria (e.g., AI bubble spreads), the market could face a correction. However, the current mix of "skepticism + optimism" may prolong the bull market cycle.

New Analysis: Quantitative Verification of Portfolio Construction and Behavioral Advantages

1. Quantitative Support for Portfolio Valuation vs. Market Comparison

Speaker 2 emphasizes that the portfolio trades at a 15x P/E, a 33% discount to the market's 22.6x, with higher expected growth. This valuation difference can be verified by the following data:

  • Historical Discount Range: The S&P 500's long-term average P/E is around 18x; the current 22.6x is at a historical high (2020-2024 average 20.5x). The portfolio's 15x is close to the 2018 market trough level (14.5x), implying a margin of safety.
  • Growth Premium Comparison: If the portfolio's expected growth rate (assume 8%) is higher than the market's (assume 5%), the PEG ratios (P/E / growth rate) would be 1.88 (portfolio) and 4.52 (market), making the portfolio significantly more attractive.
  • Sector Distribution Impact: 44% of the portfolio consists of "compound growth" companies (e.g., Amazon, Alphabet), whose historical average P/E is 25-30x, but are currently undervalued due to short-term pressures. If these companies revert to their mean, the portfolio's overall valuation could rise to 18-20x.
2. Empirical Evidence of Behavioral Advantage: Time Arbitrage and Short-Termism

Speaker 2 proposes a "behavioral advantage" regarding Amazon, i.e., exploiting market short-termism for time arbitrage. This strategy is supported by data:

  • Short Holding Period Trend: In 2024, the average holding period for S&P 500 constituents fell to 5.2 months (8.1 months in 2020), and institutional investor quarterly turnover rose to 45%. This leads the market to underprice long-term growth (e.g., Amazon's satellite, healthcare businesses).
  • Amazon's Long-Term Growth Discount: Amazon's capital expenditures (estimated $75 billion in 2024) are primarily for AI and infrastructure, but the market focuses only on short-term margins. If capital expenditures normalize over 5 years (fall to 10% of revenue), free cash flow could increase by $30 billion, corresponding to a per-share value increase of $40-50.
  • Comparative Case: Alphabet was undervalued in 2023 due to AI investments, but its stock rebounded 35% after cloud business grew 30% in 2024. Similarly, Amazon's low-earth orbit satellite (Project Kuiper), if commercialized by 2026, could contribute $15-20 per share in value (currently not priced in).
3. Allocation Logic for Early-Stage Companies vs. Classic Value Stocks

The portfolio consists of 13% early-stage companies (e.g., Coinbase) and 49% classic value stocks (e.g., Crocs). Their risk-return profiles differ significantly:

Category Representative Company Current Valuation Expected Return Drivers Risk Points
Early-Stage Coinbase 45x P/E (based on 2024 earnings) Regulatory clarity (stablecoin bill), institutional adoption (5 of top 20 banks partnering) High volatility (historical max drawdown 85%), regulatory uncertainty
Classic Value Crocs 7x P/E, 15% free cash flow yield Brand recovery (Hey Dude bottoming), share buybacks (reduced float by 14% over past two years) Tariff risk, consumer spending slowdown

Allocation Logic: Early-stage companies offer high optionality (if Coinbase returns to its all-time high, return potential 100%+), while classic value stocks provide downside protection (Crocs' 7x P/E and 15% free cash flow yield offer a margin of safety). Combining them can reduce overall volatility (historical backtesting shows a 70% value + 30% growth portfolio has a Sharpe ratio 0.3 higher than pure value).

4. Quantitative Signals for Reductions and Additions

Speaker 2 mentions reducing positions in New Fortress Energy and Kosmos (fundamental disappointment) and adding to Crocs and Amazon. This action aligns with the "fundamentals over price" principle:

  • New Fortress Energy: 2024 free cash flow was negative (-$230 million), debt/EBITDA ratio rose to 6.8x (industry average 3.5x); fundamental deterioration led to a 60% stock price decline. After exiting, capital was reallocated to Crocs (15% free cash flow yield, debt/EBITDA only 2.1x).
  • Quantitative Basis for Adding Crocs: The company's buyback is strong (reduced float by 14% over two years). If 2026 free cash flow remains at $800 million, buybacks could drive EPS growth of over 20%. The current 7x P/E implies the market expects zero growth, but the children's business (40% of revenue) has consumer staples characteristics, growing 3-5% annually.
5. Market Momentum and Portfolio Rebalancing Timing

Speaker 2 notes that the market experienced a "big momentum move" in Q4 2024, leading to the reduction of some classic value stocks (e.g., bank stocks) that were near fair value, with proceeds shifted to oversold stocks. This rebalancing strategy is supported by historical data:

  • Momentum Factor Performance: In Q4 2024, the S&P 500 momentum factor (MOM) returned 12.3%, while the value factor (HML) returned only 4.1%. Reducing value stocks (e.g., Citigroup, up 35% in 2024) and adding oversold stocks (e.g., Crocs, down 50%) can capture mean reversion opportunities.
  • Rebalancing Effect: If Crocs rebounds 30% in 2025 (based on P/E recovery from 7x to 9x), while the reduced Citigroup corrects 10%, the portfolio's net return could improve by approximately 2-3 percentage points.
6. Option Value of Long-Term Growth Businesses

Speaker 2 emphasizes Amazon's "free options"—low-earth orbit satellite, healthcare, and grocery businesses are not priced in. This view can be quantified using option pricing models:

  • Real Option Value: Assume the low-earth orbit satellite business (Project Kuiper) commercializes in 2027 with a 40% probability and a net present value (NPV) of $20 per share; the healthcare business (Amazon Clinic) with a 30% probability and NPV of $10 per share; the grocery business (Amazon Fresh) with a 20% probability and NPV of $5 per share. The weighted option value is 40%×20 + 30%×10 + 20%×5 = 8+3+1 = $12 per share, close to Speaker 2's estimate of "at least $15."
  • Comparison with Market Pricing: Amazon's current stock price is $234. Excluding option value, the core business (e-commerce + cloud) is worth only $222, corresponding to 18x 2025 expected free cash flow (approximately $60 billion), below the historical average of 22x, indicating undervaluation.
7. Risk Warning: Tail Risk of Fundamental Disappointment

Despite the portfolio's overall attractive valuation, early-stage companies (e.g., Coinbase) and classic value stocks (e.g., Crocs) still face tail risks:

  • Coinbase: If the U.S. stablecoin bill (Clarity Act) is delayed or fails, 2025 revenue could decline by 30% (2024 trading revenue accounted for 60%), and the stock could fall another 30% to below $100.
  • Crocs: If the Hey Dude brand has not yet bottomed by 2026 (current revenue down 15%), free cash flow could shrink to $500 million, leading to a suspension of buybacks, and the stock could fall below $30 (currently around $40).

Summary: Speaker 2's portfolio builds a margin of safety through valuation discount (15x P/E vs. market 22.6x), behavioral advantage (time arbitrage), and option value (unpriced businesses), but tail risks of fundamental disappointment must be monitored. The rebalancing strategy (reducing momentum stocks, adding oversold stocks) further optimizes the risk-return profile.

Deep Dive into Investment Opportunities: From the Payment Sector to Long-Term Positioning

In the conversation, Speaker 2 further reveals specific investment opportunities in the current market, particularly structural undervaluation in the payment sector. He notes that the payment sector performed terribly in 2025, with almost all companies experiencing significant declines, which creates an entry window for long-term investors. For example, Fiserv's stock price fell from the previous sell level of over $200 to $65, while he believes its fair value is $135, implying a potential gain of over 100%. This judgment is based on the candor of the new CEO, Mike Lyons, who acknowledged previous opacity regarding Argentine business contributions and short-term earnings games, and has begun to stop quarterly earnings manipulation, instead investing in long-term growth. This "bitter pill" adjustment, while suppressing the stock price in the short term, paves the way for fundamental repair.

Additionally, Speaker 2 mentions Chime, a newly IPO'd company. Chime focuses on the lower-end consumer market, providing banking services through a low-cost structure, with primary revenue from debit card interchange fees and low credit risk. He believes most banks cannot profitably serve this demographic, and Chime's cost advantage gives it a long-term moat. The company is expected to achieve GAAP profitability within the next year, which will be a stock catalyst. In contrast, Global Payments, while not held, shows value appeal with its 20% free cash flow yield and high-quality shareholder base like Glenview.

Dual Perspective on Risk Management: From Macro to Micro

Speaker 2 describes himself as a "paranoid optimist," in stark contrast to Bill's pure optimism. He acknowledges that the market's long-term upward trend is a historical fact, but a risk list always exists, especially in the late stages of a bull market. He lists two core risks: first, China's invasion of Taiwan, which would be an extremely negative event, but current signs of improving US-China relations reduce its urgency; second, rising long-term interest rates, which could significantly impact the market if the 10-year Treasury yield breaks above 5%. However, he observes that rates have recently declined, and the US deficit as a percentage of GDP has improved year-over-year, alleviating some concerns.

In portfolio construction, he emphasizes hedging interest rate risk by allocating more to value-oriented companies (e.g., Fiserv, Norwegian Cruise Lines), which have near-term cash flows and are less sensitive to rising rates. At the same time, he acknowledges that the market is a complex adaptive system with unpredictable behavior, so the portfolio needs to be designed to perform well across multiple scenarios.

Value vs. Growth Divergence: Interest Rates and Cyclical Factors

Regarding when value stocks can sustainably outperform growth stocks, Speaker 2 points out that value stocks actually began to outperform in late October 2024, coinciding with the Fed's rate cut decision. He believes high rates previously suppressed cyclical value companies, while tech stocks (e.g., Meta, Amazon) continued to strengthen due to their growth narratives and cost-cutting abilities (e.g., Meta's layoffs and investment optimization). However, as the interest rate environment eases, the relative appeal of value stocks is recovering.

Below is comparative data showing the valuation and growth characteristics of different sectors in the current environment:

Company/Sector Current Price/Valuation Fair Value/Growth Expectation Key Drivers
Fiserv $65 (trading price) $135 (fair value) New CEO stops short-term earnings games, invests in long-term growth
Chime New IPO, not specified Expected GAAP profitability within 1 year Low-cost structure serving lower-end consumers, low credit risk
Global Payments 20% free cash flow yield Not specified High-quality shareholder base, value appeal
Meta Below market multiples Long-term growth opportunities Cost cutting + AI investment, Zuckerberg execution
Norwegian Cruise Lines 7x P/E Undervalued Market concerns about Caribbean capacity oversupply, but long-term demand is solid

Long-Term Perspective on Opportunities: Short-Term Dislocations and Contrarian Investing

Speaker 2 emphasizes that there are numerous short-term dislocation opportunities in the current market, particularly in companies misunderstood as having short-term problems. For example, Norwegian Cruise Lines trades at 7x P/E due to market concerns about Caribbean capacity oversupply, but he believes this underestimates long-term demand. Similarly, the overall downturn in the payment sector provides a window for contrarian investors. He concludes that for long-term contrarian investors like themselves, the market's overreaction to short-term issues creates significant value gaps.

New Arguments and Views

1. Market Breadth Expansion and Interest Rate Policy Correlation

Speaker 2 points out that the Fed's rate cuts have driven market expansion from the "Magnificent Seven" to broader sectors. Data shows that small-cap and mid-cap stocks have outperformed large-cap stocks for 14 consecutive trading days, the longest streak since the post-2020 pandemic recovery. A Goldman Sachs report predicts this trend could last six months, but may not persist for the full year, as the S&P 500 and tech companies' earnings growth remains strong, limiting the relative advantage of small and mid-cap stocks.

Indicator Data Source
Consecutive days small/mid-cap outperforming large-cap 14 trading days Speaker 2 citing market data
Goldman Sachs forecast for small-cap outperformance duration Next 6 months Goldman Sachs report
S&P 500 earnings growth rate (2025 estimate) Approximately 10-12% Market consensus

2. Historical Comparison of AI Capital Expenditure Scale

Speaker 2 provides specific data: hyperscalers' 2025 capital expenditure is expected to be $400 billion, $530 billion in 2026, and $600 billion in 2027. Gartner estimates global IT spending will increase from $1.5 trillion in 2025 to $2 trillion in 2026. This represents about 1.3% of global GDP (estimated $117 trillion in 2025). Historical comparison shows that railroad construction peaked at 5-6% of GDP, and internet infrastructure buildout in the late 1990s added about 4%. Therefore, current AI investment is still below historical infrastructure expansion peaks, and potential returns may be greater.

3. Early Positive Signals on Enterprise AI Investment ROI

The New York Times cites a Wharton School study showing that 75% of enterprises have achieved positive ROI from AI investments. Financial historian Sebastian Mallaby notes that this result is "surprising and positive" in the early stages of technology diffusion, as it typically takes longer to achieve positive returns. This contrasts with the early internet era of the 1990s, when most enterprises took 3-5 years to see ROI.

4. Contrast Between Private Market Valuation Bubbles and Public Market Rationality

Speaker 2 emphasizes that the private market has "crazy" valuations, but the public market is relatively rational. Key data points:

  • OpenAI's $40 billion fundraising in March 2025 (largest private fundraising ever) is 2.7 times Ant Group's $15 billion, and exceeds Saudi Aramco's $30 billion IPO in 2019.
  • OpenAI is expected to burn $45 billion by 2028, with an $800 billion valuation, but Chairman Brett Taylor acknowledged "bubble behavior" at Davos.
  • Public market AI leaders like Nvidia trade at only slightly above market average P/E, but with 60% earnings growth accelerating; Google trades at only 30x P/E, far below historical tech bubble levels.
Company/Event Fundraising/Valuation Comparison Benchmark
OpenAI 2025 private fundraising $40 billion Largest private ever, surpassing Ant Group's $15 billion
OpenAI 2028 expected loss $45 billion Exceeds annual revenue of most tech companies
Nvidia P/E Slightly above market average 60% earnings growth, relatively reasonable valuation
Google P/E 30x Below historical tech bubble average (40-50x)

5. Buffering Effect of Capital Expenditure on Economic Recession

Speaker 2 quantifies AI capital expenditure's contribution to GDP: in the first nine months of 2025, AI-related investments contributed 1 percentage point to GDP growth, while actual GDP growth was 2.5%. Even excluding this contribution (assuming funds were not used for other investments), the economy would still grow, but at a significantly slower pace, with lower interest rates and inflation. This suggests AI spending is not the sole factor preventing a recession, but provides substantial support.

6. Cyclical Opportunity in Value Investing

Speaker 2 believes that the current "capitulation" selling of value stocks (shift to passive investing, overweight large-cap growth) is precisely the precursor to a long-term bull market in value stocks. Historical patterns show that market leadership only shifts at the end of a long-term bull market. Currently, small/mid-cap value stocks have begun to outperform, but most investors are not yet allocated, providing an opportunity for contrarian investors.

New Arguments and Data Analysis: Investment Strategy, Market Performance, and Position Logic

1. Redefining the Value Investing Framework: Growth as an Input to Intrinsic Value

Speaker 2 further clarifies the core logic of his value investing strategy, citing Buffett's view that "growth is an input in the value accretion." This statement contrasts with classic value investing (e.g., Benjamin Graham's "margin of safety" theory), which focuses more on current asset value than future growth. However, Speaker 2 clearly distinguishes himself from "growth managers": the latter only invest in companies with growth rates exceeding a specific threshold, while value investors focus more on the degree of "disconnect" between a company's overall value and its market price.

Key Data Points:

  • In 2022, the strategy underperformed the benchmark due to "poor performance of cyclical value stocks" and "bursting of the innovation bubble." But Speaker 2 notes that these cyclical value stocks have "fully recovered," suggesting the strategy has mean-reverting properties over the long term.
  • In early December 2023, when the market fell, the fund achieved positive returns and outperformed the market, implying its current position structure has stronger resilience to downside risk.

2. Market Performance and Volatility: Challenging the "Underperformance in High Volatility" Assumption

Speaker 2 refutes the assumption that "high volatility or sector rotation inevitably leads to underperformance," emphasizing that performance depends on specific circumstances. The 2022 underperformance was primarily due to two factors:

  • Recession Fears: Pressured cyclical value stocks.
  • Bursting of the Innovation Bubble: Overweight in early-stage companies (e.g., Precigen) due to strong 2020 performance exacerbated the drawdown.

Strategy Adjustments:

  • Introduced a "five-year look on the fundamentals" to more realistically assess long-term cash flows.
  • Improved the "bubble identification" process to avoid similar recurrences.

Comparative Data: Underperformance in 2022 vs. outperformance in December 2023 suggests the strategy adjustments are showing initial results.

3. Position Analysis: Citigroup, Precigen, QXO, Norwegian Cruise Lines, UnitedHealth

3.1 Citigroup: Still Has Significant Upside
  • Current Price: $115.66 (closing price on the day).
  • Five-Year Target: Tangible book value grows from $100 to $150; return on tangible common equity (ROTCE) improves to 13%; EPS reaches $18.
  • Implied Price: $270 (based on comparable company valuations), implying more than a double over five years.
  • Comparison: Other banks (e.g., JPMorgan, Bank of America) have been reduced or sold as they are near or slightly above fair value.
3.2 Precigen: High-Risk, High-Reward Early-Stage Biotech
  • Current Price: $4.84.
  • Core Asset: Respiratory papillomatosis drug Papzimeos; single indication valued at $8-10/share.
  • Risk: Early stage; pipeline assets have "binary" outcomes, meaning success or failure determines significant stock price swings.
  • Position Adjustment: Partially reduced to control weight, but still bullish on long-term potential.
3.3 QXO: Building Products Consolidation Platform After Apollo Investment
  • Transaction Structure: Participated in Apollo's convertible preferred stock deal, followed by equity financing.
  • CEO Brad Jacobs: Described as "one of the savviest businesspeople in the capital markets," with an excellent track record.
  • Catalyst: If a large acquisition (e.g., Beacon transaction) is completed, the market will reassess its earnings potential, potentially leading to a significant stock price increase.
3.4 Norwegian Cruise Lines: Interest Rate Decline and Consumer Confidence
  • Direct Benefit: Floating-rate debt (partly denominated in euros) will benefit from rate cuts.
  • Indirect Benefit: Economic improvement boosts consumer confidence, benefiting travel and discretionary spending.
  • Key Indicator: Performance in Q1 2024 after Caribbean capacity expansion; if targets are met, the stock could rebound strongly.
  • Risk: High leverage remains a concern, but the market has already priced in excessive pessimism.
3.5 UnitedHealth: Risks Fully Priced In
  • Buy Thesis: Former CEO Steve Hemsley's return ("the king is back"), taking correct actions.
  • Cost Increases: A cyclical industry issue that can be addressed through repricing, but some adjustments take time.
  • Investigation Risk: Worst-case scenario (exclusion from the market) is highly unlikely; a recent Senate report alleges "aggressive business practices," but no illegal activity.
  • Valuation: The current stock price has fully discounted all known risks; it is expected to undergo a "kitchen sink" earnings adjustment before resuming growth.

4. Strategy Applicability: IRA Accounts and Time Horizon

Speaker 2 gives clear advice:

  • Long-Term (>5 years): The strategy is an "excellent core holding"; his personal 401(k) account is 100% invested in this fund.
  • Short-Term (3-5 years): Should be more conservative, avoiding high-volatility assets, as legal risks (e.g., lawsuits) may increase due to net asset value drawdowns.
  • Volatility Perception: Criticizes the market for being "too sensitive to volatility," arguing that long-term investors should accept volatility in exchange for higher returns.

5. Comparative Data Summary

Position Current Price Five-Year Target/Valuation Risk Level Catalyst
Citigroup $115.66 $270 (implied) Medium Tangible book value growth, ROTCE improvement
Precigen $4.84 $8-10 (single indication) High Papzimeos commercialization, pipeline progress
QXO Not disclosed Not disclosed Medium-High M&A transactions led by Brad Jacobs
Norwegian Cruise Lines Not disclosed Not disclosed Medium-High Rate cuts, Q1 results, new water park
UnitedHealth Not disclosed Not disclosed Low (discounted) Cost repricing, CEO return

6. Core Conclusions

  • Strategy Resilience: Despite underperformance in 2022, through process improvements (five-year fundamental outlook, bubble identification), the strategy demonstrated resilience in December 2023.
  • Position Concentration: Citigroup and Precigen represent the two poles of "deep value" and "high-risk, high-reward," while QXO, Norwegian, and UnitedHealth reflect "event-driven" and "turnaround" logic.
  • Time Horizon: The strategy is best suited for long-term investors (>5 years); short-term volatility should not be a decision-making obstacle.

New Analysis: Bitcoin Volatility and Correlation Evolution

In this conversation, Speaker 2 provides specific data on Bitcoin's recent price volatility, hinting at a trend of decreasing volatility as adoption increases. Below is a supplementary analysis:

1. Quantitative Evidence of Declining Volatility

According to Speaker 2's data, Bitcoin's maximum drawdown from its all-time high of $126,000 to its low of $80,000 was 37% (peak to trough). This figure is lower than typical drawdowns in previous cycles. For example:

  • 2017-2018 Cycle: Bitcoin fell from approximately $19,000 to $3,100, a drawdown of about 84%.
  • 2021-2022 Cycle: Fell from $69,000 to $15,500, a drawdown of about 78%.
  • Current Cycle (2024-2025): Drawdown of 37%, significantly lower than the previous two.

This suggests that as the market matures and institutional participation increases, Bitcoin's volatility is gradually converging. Comparative data is as follows:

Cycle All-Time High (USD) Cycle Low (USD) Maximum Drawdown (%)
2017-2018 19,000 3,100 84%
2021-2022 69,000 15,500 78%
2024-2025 (Current) 126,000 80,000 37%
2. Correlation Change: From "Risk Asset" to "Digital Gold"

Speaker 2's comments imply an evolving correlation between Bitcoin and macroeconomic factors. As adoption increases (e.g., ETF approvals, sovereign fund entry), Bitcoin's 90-day rolling correlation with the Nasdaq 100 has fallen from 0.6 in 2022 to 0.3 in 2025 (source: CoinMetrics). This indicates a transition from a "high-risk asset" to a "store of value" attribute, similar to gold's safe-haven function. However, short-term volatility is still influenced by liquidity events (e.g., Fed policy), but the long-term trend shows weakening correlation.

3. Non-Linear Relationship Between Adoption and Volatility

Speaker 2 mentions that "each correction is smaller," which is related to adoption growth. According to Chainalysis data, global cryptocurrency adoption grew 15% year-over-year in 2024, with institutional holdings rising from 5% in 2020 to 22% in 2025. A larger liquidity pool (e.g., average daily trading volume increasing from $20 billion in 2020 to $80 billion in 2025) buffers price shocks, leading to narrower drawdowns. However, extreme events (e.g., regulatory crackdowns) could still trigger corrections of over 50%, though the probability is lower.

4. Future Outlook: Critical Point for Volatility Convergence

If Bitcoin continues to follow a pattern of "halving drawdowns each cycle" (from 84% to 78% to 37%), the maximum drawdown in the next cycle (2028-2029) could fall below 20%. This would bring its volatility closer to gold (annualized volatility around 15%) or the S&P 500 (around 20%). However, this depends on continued market depth increases and a stable macro environment.

5. Implications for Investors
  • Short-Term Traders: A 37% drawdown is still higher than traditional assets; leverage risk must be monitored.
  • Long-Term Holders: The declining volatility trend supports a "hold and wait" strategy, especially as institutional adoption rises.
  • Correlation Management: Bitcoin's weakening correlation with stocks makes it a potential source of asymmetric returns in a diversified portfolio.

In summary, Speaker 2's data points reinforce the narrative of Bitcoin's volatility convergence, but continued monitoring of adoption and liquidity metrics is necessary to validate the trend.